The IHC analyses revealed that 76.1% of all pMMR CRCs were cGAS-negative expressions, and 70.8% of all pMMR CRCs were STING-negative expressions in tumor cells (Figure 1A,B). This evidence concerns the gene STING1 and neoplasm.